Zuojin Wan Combined With Woonosan Fumarate for the Treatment of GRD Combined With Depression

Summary

To evaluate the improvement of symptoms in patients with gastroesophageal reflux disease combined with depression (hepatic and gastric depression-heat type) by Zuojin Wan combined with vornodine fumarate regimen as a control, and to compare the adherence to the medication and the adverse reactions of the patients between the two groups.

Timeline

Start

2024-06-30

Primary completion

2026-04-30

Completion

2026-06-30

Drugs

Indications